This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

ServiceSource, Illumina: After-Hours Trading

Stocks in this article: SREV ILMN AFFX BRKR LIFE

NEW YORK ( TheStreet) -- Shares of ServiceSource (SREV) jumped in late trades on Thursday after the company gave a strong outlook for its fiscal third quarter.

The San Francisco-based provider of cloud-based service revenue management technology forecast adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) above $2.5 million for the three months ended Sept. 30 with revenue seen exceeding $49 million.

For the full year, the company now expects revenue above $195 million, better than its prior projection for revenue ranging from $190 million to $192 million.

The current average estimates of analysts polled by Thomson Reuters are revenue of $46.1 million in the September quarter and $191.9 million for the year. The company's prior forecast was for adjusted EBITDA of between $500,000 and $1 million, and revenue of $45 million to $46 million.

ServiceSource also said it expects net income and non-GAAP earnings per share to come in above its previous guidance for a net loss of $4.5 million to $5 million and non-GAAP results of between breakeven and a loss of a penny per share.

The stock was last quoted at $15, up 12.4%, on volume of more than 100,000, according to Wall Street was bullish on ServiceSource ahead of the news with nine of the 10 analysts covering the stock at either strong buy (3) or buy (6).

ServiceSource went public in late March, selling nearly 12 million shares at $10 each. The stock reached a high of $23.60 on June 30.


Illumina (ILMN) was the big loser in the extended sesssion, dropping more than 20% after the San Diego life science technology developer said its third-quarter revenue would come in well below Wall Street expectations and suspended its outlook for the rest of the year.

The company said it now sees revenue of $235 million for the September-ended quarter vs. the average analysts' view for revenue of $278 million. Illumina attributed the shortfall to delays in customer purchases because of the uncertain economy, excess capacity created by a new product launch in the second quarter, a drop in reagent usage for its Genome Analyzer installed customer base, and lower than expected upgrades to its HiSeq 2000 systems.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs